Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-09-14 4:30 pm Unchanged |
2009-02-28 | 13D | POINT Biopharma Global Inc. PNT |
RA Capital Management, L.P. | 8,856,018 9.800% |
0 (Unchanged) |
Filing History |
| 2021-07-20 4:31 pm Purchase |
2021-07-20 | 13G | POINT Biopharma Global Inc. PNT |
RA Capital Management, L.P. | 8,856,018 9.800% |
8,856,018 (New Position) |
Filing History |
| 2021-07-12 4:37 pm Purchase |
2021-06-30 | 13D | POINT Biopharma Global Inc. PNT |
SILBER ALLAN C | 8,865,788 9.800% |
8,865,788 (New Position) |
Filing History |
| 2021-06-30 4:32 pm Purchase |
2021-06-24 | 13D | Therapeutics Acquisition Corp. RACA |
RA Capital Management, L.P. | 1,098,318 7.800% |
1,098,318 (New Position) |
Filing History |
| 2021-05-10 4:08 pm Purchase |
2021-05-04 | 13G | Therapeutics Acquisition Corp. RACA |
RIVERVIEW GROUP LLC | 940,000 6.700% |
940,000 (New Position) |
Filing History |
| 2021-04-02 10:59 am Purchase |
2021-03-23 | 13G | Therapeutics Acquisition Corp. RACA |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,095,400 7.800% |
1,095,400 (New Position) |
Filing History |
| 2021-02-16 3:45 pm Purchase |
2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA |
PERCEPTIVE ADVISORS LLC | 1,500,000 10.700% |
1,500,000 (New Position) |
Filing History |
| 2021-02-16 12:24 pm Purchase |
2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA |
PRICE T ROWE ASSOCIATES INC | 921,822 5.200% |
921,822 (New Position) |
Filing History |
| 2021-02-12 7:58 pm Sale |
2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA |
BIOTECHNOLOGY VALUE FUND L P | 954,996 6.800% |
-45,004 (-4.50%) |
Filing History |
| 2021-02-12 08:10 am Purchase |
2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA |
AVORO CAPITAL ADVISORS LLC | 1,000,000 7.100% |
1,000,000 (New Position) |
Filing History |
| 2021-02-05 5:51 pm Unchanged |
2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA |
BLACKROCK INC BLK |
1,500,000 10.700% |
0 (Unchanged) |
Filing History |
| 2021-02-04 10:27 am Purchase |
2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA |
WELLINGTON MANAGEMENT CO LLP | 877,832 6.250% |
877,832 (New Position) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA |
FRANKLIN RESOURCES INC BEN |
1,000,000 7.100% |
1,000,000 (New Position) |
Filing History |
| 2020-09-09 3:52 pm Purchase |
2020-08-31 | 13G | Therapeutics Acquisition Corp. RACA |
BLACKROCK INC BLK |
1,500,000 10.700% |
1,500,000 (New Position) |
Filing History |
| 2020-07-20 4:37 pm Purchase |
2020-07-10 | 13G | Therapeutics Acquisition Corp. RACA |
Boxer Capital LLC | 1,500,000 8.800% |
1,500,000 (New Position) |
Filing History |
| 2020-07-20 4:35 pm Purchase |
2020-07-08 | 13G | Therapeutics Acquisition Corp. RACA |
BIOTECHNOLOGY VALUE FUND L P | 1,000,000 5.900% |
1,000,000 (New Position) |
Filing History |
| 2020-07-20 4:16 pm Purchase |
2020-07-10 | 13G | Therapeutics Acquisition Corp. RACA |
Bain Capital Life Sciences Fund II, L.P. | 891,429 6.300% |
891,429 (New Position) |
Filing History |